If you went to college in the 60s and 70s, you can use the "munchies" or cravings that sometimes accompanied by smoking marijuana. Little has realized the pot heads that the day that drugs in the future, which block the cravings would help them throw the pounds that over the next 30 years or so to win.
These new drugs, Rimonabant (affectionately known to metabolism.com as Ramona), brand name Acomplia is currently available in Europe and may soon be available to the United States. The company that makes the drug, Sanofi-Aventis in lengthy negotiations with the FDA regarding gaining the critical approval needed to bring to market Acomplia, were produced in the U.S. There has been much speculation about the reasons for the long delays in collection was approved by the FDA. One possible reason is that although large-scale clinical trials suggest that the new drug is safe and effective for weight loss, many experts are concerned about potential side effects of ramonabant concerned.
Studies show that losing approximately 30-40% of obese people under ramonabant more than 5% of their body weight and 10-20% of patients more than 10% of their body weight over what they lost on diet alone lost. As Ramona enters the liver, as well it had positive effects on triglycerides and other fats in the blood. Hypotension was also observed with Ramona treatment.
Buy Rimonabant known acts by blocking an important chemical in the brain as a way the endocannabinoid system. Scientists believe that our bodies naturally produced substances similar to cannabis (marijuana, pot, reefer erc.) Interacting with the endocannabinoid system. The endocannabinoid system participates not only in the control of appetite, but in many areas of the body including the gastrointestinal tract, mood regulation, bone development, muscle control, blood pressure, adapt to the stress and reproductive system active. Some experts like the University of Colorado at Colorado Springs biology professor Dr. Robert Melamed have warned that long-term use of Ramona for weight loss could result in unwanted side effects with these other body systems. In fact, depression is one of the side effects that may impact Ramona's deadline, listed in approximately 3% of the obese subjects in a weight loss study. Nausea was another important limitation byproduct.
Industry insiders speculate that Acomplia available for consumers in the U.S. may be available, by this summer, but nobody knows for sure. Insurance companies in the U.S. do not pay for drugs for weight loss. Only one drug, a medical illness or condition subject to be treated "by an insurance company. For this reason, it is presumed that Sanofi-Aventis will use the FDA for approval, Ramona in the treatment of diabetes approach. This is because many diabetics see an improvement in their blood as they fall, and because Ramona is a direct positive effect on glucose and cholesterol have regulation, as well. It will then stop until the FDA's analysis of the safety and efficacy of the drug for this purpose. How long will last is anyone's guess.
In the meantime, we have to wait and wait and wait, Ramona. On metabolism.com we have thought that if our members wrote a song about their feelings to help in this matter could be.
skip to main |
skip to sidebar
